JPS63146809A - Composition for oral cavity - Google Patents
Composition for oral cavityInfo
- Publication number
- JPS63146809A JPS63146809A JP29445786A JP29445786A JPS63146809A JP S63146809 A JPS63146809 A JP S63146809A JP 29445786 A JP29445786 A JP 29445786A JP 29445786 A JP29445786 A JP 29445786A JP S63146809 A JPS63146809 A JP S63146809A
- Authority
- JP
- Japan
- Prior art keywords
- zeolite
- acid
- halitosis
- treated
- oral cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 210000000214 mouth Anatomy 0.000 title abstract description 7
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000010457 zeolite Substances 0.000 claims abstract description 54
- 229910021536 Zeolite Inorganic materials 0.000 claims abstract description 53
- 239000002253 acid Substances 0.000 claims abstract description 24
- 239000002245 particle Substances 0.000 claims abstract description 5
- 229910052680 mordenite Inorganic materials 0.000 claims abstract 2
- JYIMWRSJCRRYNK-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical group O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4] JYIMWRSJCRRYNK-UHFFFAOYSA-N 0.000 claims 1
- 206010006326 Breath odour Diseases 0.000 abstract description 14
- 208000006558 Dental Calculus Diseases 0.000 abstract description 10
- 230000003405 preventing effect Effects 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 208000007565 gingivitis Diseases 0.000 abstract description 5
- 206010044029 Tooth deposit Diseases 0.000 abstract description 4
- 229940112822 chewing gum Drugs 0.000 abstract description 4
- 235000015218 chewing gum Nutrition 0.000 abstract description 4
- 239000000551 dentifrice Substances 0.000 abstract description 3
- 208000032139 Halitosis Diseases 0.000 abstract 5
- 238000002156 mixing Methods 0.000 abstract 2
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 7
- -1 sucrose long chain fatty acid ester Chemical class 0.000 description 7
- 239000000606 toothpaste Substances 0.000 description 7
- 229940034610 toothpaste Drugs 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 201000001245 periodontitis Diseases 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 239000007910 chewable tablet Substances 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 150000002646 long chain fatty acid esters Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229910014033 C-OH Inorganic materials 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 229920001412 Chicle Polymers 0.000 description 1
- 229910014570 C—OH Inorganic materials 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 240000001794 Manilkara zapota Species 0.000 description 1
- 235000011339 Manilkara zapota Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940024545 aluminum hydroxide Drugs 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- YLZSIUVOIFJGQZ-UHFFFAOYSA-N bis[4-(dimethylamino)phenyl]methanol Chemical compound C1=CC(N(C)C)=CC=C1C(O)C1=CC=C(N(C)C)C=C1 YLZSIUVOIFJGQZ-UHFFFAOYSA-N 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229960001378 dequalinium chloride Drugs 0.000 description 1
- LTNZEXKYNRNOGT-UHFFFAOYSA-N dequalinium chloride Chemical compound [Cl-].[Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 LTNZEXKYNRNOGT-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229940045944 sodium lauroyl glutamate Drugs 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、歯石の形成を妨げて歯肉炎や歯槽膿漏を予防
し、また同時に口臭の原因となる物質を吸着除去して口
臭を予防する口腔用組成物に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention prevents gingivitis and alveolar pyorrhea by preventing the formation of tartar, and at the same time prevents bad breath by adsorbing and removing substances that cause bad breath. The present invention relates to an oral composition.
歯肉炎や歯槽膿漏は歯垢および歯石が直接的原因となっ
て発生することが知られている。It is known that gingivitis and alveolar pyorrhea are directly caused by dental plaque and tartar.
歯垢は様々な口腔細菌が歯に吸着、増殖して形成した粘
着性物質で、歯石はこの歯垢がさらに唾液中のカルシウ
ムやJellによって石灰化したものである。歯垢は歯
刷子で容易に除去しうるが、歯石はスケーリングによっ
て削りおとさねば除去できない。よって、歯石の形成を
予防する歯磨剤などを用いて歯磨きを行うことは歯肉炎
や歯槽膿漏の予防に効果があると考えられ、歯石予防を
訴求した種々の口腔用薬剤やその組成物が提案されてい
る。Dental plaque is a sticky substance formed by various oral bacteria adsorbed to teeth and multiplied, and dental tartar is the plaque that is further calcified by calcium and Jell in saliva. Plaque can be easily removed with a toothbrush, but tartar cannot be removed unless it is ground down by scaling. Therefore, brushing your teeth with a toothpaste that prevents tartar formation is thought to be effective in preventing gingivitis and alveolar pyorrhea, and various oral drugs and their compositions that claim to prevent tartar have been developed. Proposed.
ゼオライトそのものは既に歯磨剤などに配合され、その
歯石予防効果も実証されておシ、またさらに!i磨用と
して特に微細なゼオライトが歯石予防に有効だとして特
許出願されている(公開特許公報、昭55−24112
)。Zeolite itself has already been incorporated into toothpaste and other products, and its tartar prevention effect has been proven. A patent application has been filed for a particularly fine zeolite used for i-brushing as being effective in preventing tartar (Public Patent Publication, 1972-24112).
).
一方、歯肉炎や歯槽膿漏の患者はしばしば強い口臭を持
つが、これはおもに口腔内で生成したメチルメルカプタ
ンや硫化水素などの揮発性硫化物が呼気に含まれるため
と言われている。ゼオライトによってこれらの口臭原因
物質を吸着除去すれば、歯石予防に加えて口臭予防にも
効果的と考えられるが、ゼオライトは乾燥した系では硫
化水素やアンモニアに対して優れた吸着作用を示すもの
の、口腔内のような水が多量に共存する系では、水を最
も優先して吸着するために、効果が現れにくいという問
題があった〔小山田晃雄;ゼオライトによる消臭・脱臭
作用について、「フラグランス・シャーナル」黒72
(1985)P79−82)。On the other hand, patients with gingivitis and alveolar pyorrhea often have strong bad breath, which is said to be mainly due to the presence of volatile sulfides such as methyl mercaptan and hydrogen sulfide produced in the oral cavity in their breath. If zeolite adsorbs and removes these substances that cause bad breath, it is thought to be effective in preventing not only tartar but also bad breath. However, although zeolite shows excellent adsorption effects on hydrogen sulfide and ammonia in a dry system, In systems where a large amount of water coexists, such as in the oral cavity, the problem is that water is adsorbed with the highest priority, making it difficult to see any effects [Akio Oyamada;・Sharnal” Black 72
(1985) P79-82).
斯かる実状において、本発明者は鋭意研究を行った結果
、酸で処理したゼオライトが水の共存下においても優れ
た口臭原因物質吸着作用を有することを見出し、本発明
を完成した。Under such circumstances, the present inventor conducted intensive research and found that zeolite treated with acid has an excellent adsorption effect on substances that cause bad breath even in the coexistence of water, and completed the present invention.
すなわち、本発明は、ゼオライトをpH以下になるよう
に酸で処理した酸処理ゼオライトを含有する口腔用組成
物を提供するものである。That is, the present invention provides an oral composition containing an acid-treated zeolite, which is obtained by treating the zeolite with an acid so that the pH thereof becomes lower than the pH level.
本発明において、ゼオライトとしては、合成ゼオライト
及び天然ゼオライトの何れも使用できる。ゼオライトは
、歯石予防作用の点で粒径1〜10μm程度の微細なも
のが好ましい。而して、天然ゼオライトは、このような
微細粒子にするには高度の粉砕技術を要するが、合成ゼ
オライトはその合成過程で粒子径t−調整できるので有
利である。好ましい合成ゼオライトとしては、例えばA
型、4A型、X型、Y型のゼオライト及びモルデナイト
等が挙げられる。In the present invention, both synthetic zeolite and natural zeolite can be used as the zeolite. The zeolite is preferably a fine one with a particle size of about 1 to 10 μm from the viewpoint of preventing tartar. Natural zeolite requires a sophisticated pulverization technique to form such fine particles, but synthetic zeolite is advantageous because it can adjust the particle size t during its synthesis process. Preferred synthetic zeolites include, for example, A
Examples include zeolite, mordenite, 4A type, X type, and Y type.
斯かるゼオライトの酸処理は、ゼオライトに酸を接触せ
しめることによって行われる。Such acid treatment of zeolite is carried out by bringing the zeolite into contact with an acid.
酸としては、硫酸、塩酸、硝酸等の鉱酸;クエン酸、コ
ハク酸、リンゴ酸、酒石酸等の有機酸が挙げられる。ゼ
オライトの中にはA型ゼオライトのように酸によって構
造が破壊されるものもあるので、酸は一般に1M前後の
溶液とし、これをスラリー状のゼオライトに攪拌下栓々
に加えて処理するのが好ましい。Examples of acids include mineral acids such as sulfuric acid, hydrochloric acid, and nitric acid; organic acids such as citric acid, succinic acid, malic acid, and tartaric acid. Some zeolites, such as A-type zeolite, have their structures destroyed by acid, so it is generally best to make the acid into a solution of around 1M and add this to the slurry of zeolite under stirring. preferable.
無処理のゼオライトはpH10以上であるが、当該酸処
理は、酸処理ゼオライトのpHが9以下になるまで行う
。特に、口腔内に適用することからpH13〜6になる
ように処理するのが好ましい。ゼオライトのpHは、経
時的にサンプリングしたものを、固形分が約5@@To
の水懸濁液とし、pHメーターによりそのpHを測定し
、所定のpHになった時点で処理を終了し、よく洗浄す
る。Although the untreated zeolite has a pH of 10 or more, the acid treatment is performed until the pH of the acid-treated zeolite becomes 9 or less. In particular, since it is applied to the oral cavity, it is preferable to treat it to a pH of 13 to 6. The pH of zeolite was determined by sampling over time, and the solid content was approximately 5@@To
Measure the pH using a pH meter, and when the pH reaches a predetermined value, the treatment is terminated and thoroughly washed.
斯くして得られる酸処理ゼオライトは、スラリーのまま
口腔用組成物中に配合しても、また乾燥したものを配合
してもよい。酸処理ゼオライトの配合量は、組成物の種
類に応じて全組成の1〜99重量%の広い範囲で選択で
きる。The acid-treated zeolite thus obtained may be blended into the oral composition as a slurry, or may be blended in a dried form. The amount of acid-treated zeolite to be blended can be selected within a wide range of 1 to 99% by weight of the total composition depending on the type of composition.
本発明の口腔用組成物としては、歯磨剤、チューインガ
ム、トローチ錠、噛み砕き錠などが挙げられ、酸処理ゼ
オライト以外の成分は、通常これらの製剤に使用される
ものを用いることが出来る。例えば、歯磨用研磨剤とし
て、リン酸水素カルシウム、炭酸カルシウム、水酸化ア
ルミニウム、アルミナ、含水ケイ酸、無水ケイ酸、ゾル
コニクムシリケート、不溶性メタリン酸ナトリウム、ビ
ロリン酸カルシウム、等が;発泡剤としては、ラウリル
硫酸ナトリウム、ミリスチル硫酸ナトリウム、ショ糖長
鎖脂肪酸エステル、各種アミノ酸長鎖脂肪酸アミド、長
鎖脂肪酸エタノールアミド、?リオキシエチレンアルキ
ルエーテル、?リオキシエチレン?リゾロビレンコ?リ
マー、?リオキシエチレン長鎖脂肪酸エステル、ソルビ
ット長鎖脂肪酸エステル、?リオキシエチレンソルピッ
ト長鎖脂肪酸エステル、長鎖脂肪酸塩類、す?エン類、
等が;湿潤剤としては、グリセリン、ノルビット液、ゾ
ロビレ7 f IJコール、ぎロリドンカルボン酸塩類
、等が;粘結剤としては、カルボキシメチルセルロース
ナトリウム、?リアクリル酸ナトリウム、カラギーナン
、キサンタンガム、グアガム、グイ−ガム、アラビアガ
ム、アルギン酸ナトリウム、ゼラチン、等が;甘味剤と
しては、サッカリンナトリウム、グリチルリチン酸ゾカ
リウム、甘草エキス、ノQラチノース、アス、Qルテー
ム、ステビオサイド、等が;虫歯や歯槽膿漏を予防する
有効成分としては、アスコルビン酸およびそのエステル
類、アズレン、デキストラナーゼ、ムタナーゼ、アミラ
ーゼ、プロテアーゼ、す/Q −4゛、溶菌酵素、アラ
ントインおよびその塩類、1−アミツカゾロン酸、トラ
ネキサム酸、イルガサンDP−300、ジヒドロコレス
テロール、エビジヒドロコレステロール、塩化セチルピ
リゾニウム、塩化デカリニウム、塩化ナトリウム、塩化
ベンザルコニウム、塩化ベンゼトニウム、塩化リゾチー
ム、塩酸ぎりトキシン、クロルヘキシシンの塩類、酢酸
di−α−ミーα−トコフェロールン酸dl−α−トコ
フェロール、ニコチン酸アルキルエステル、鋼クロロフ
ィリンナトリウム、トリクロロカルバニリド、ハロカル
パン、ヒノキチオール、フッ化i −スズ、フッ化ナト
リウム、?リエtレンゲリコール、モノフルオルリン酸
ナトリウム、グロ?リス、露蜂房、用弓、当帰、紅花、
等が:チューインガムのガム基剤としては、天然チクル
や酢酸ビニルが;トローチ錠、噛み砕き錠の賦型剤とし
ては、乳糖、結晶性セルロース、白糖、等が挙げられる
。また、使用感を向上させる目的でぺ、e−ミントやス
ペアミント、アネトールなどの適当な香料を加えてもよ
い。Examples of the oral composition of the present invention include dentifrice, chewing gum, troche tablets, and chewable tablets, and the components other than the acid-treated zeolite can be those normally used in these preparations. For example, as an abrasive for toothpaste, calcium hydrogen phosphate, calcium carbonate, aluminum hydroxide, alumina, hydrated silicic acid, anhydrous silicic acid, zolconicum silicate, insoluble sodium metaphosphate, calcium birophosphate, etc.; as a foaming agent, , sodium lauryl sulfate, sodium myristyl sulfate, sucrose long chain fatty acid ester, various amino acid long chain fatty acid amides, long chain fatty acid ethanolamide, ? Lioxyethylene alkyl ether,? Lioxyethylene? Ryzolovilenko? Rimmer? Lioxyethylene long chain fatty acid ester, sorbitol long chain fatty acid ester, ? Rioxyethylene Solpit long chain fatty acid esters, long chain fatty acid salts, Su? Ens,
Wetting agents include glycerin, Norbit solution, Zorobire 7 f IJ Cole, gyrolidone carboxylic acid salts, etc.; binders include carboxymethyl cellulose sodium, ? Sodium lyacrylate, carrageenan, xanthan gum, guar gum, gum gum, gum arabic, sodium alginate, gelatin, etc.; sweeteners include sodium saccharin, zopotassium glycyrrhizinate, licorice extract, NoQ latinose, as, Q luteme, stevioside, Active ingredients for preventing cavities and alveolar pyorrhea include ascorbic acid and its esters, azulene, dextranase, mutanase, amylase, protease, Su/Q-4, lytic enzyme, allantoin and its salts, 1-amitucazolonic acid, tranexamic acid, Irgasan DP-300, dihydrocholesterol, evidihydrocholesterol, cetylpyrizonium chloride, dequalinium chloride, sodium chloride, benzalkonium chloride, benzethonium chloride, lysozyme chloride, hydrochloride toxin, salts of chlorhexicine , di-α-me α-tocopherol dl-α-tocopherol acetate, nicotinic acid alkyl ester, sodium steel chlorophyllin, trichlorocarbanilide, halocarpan, hinokitiol, i-tin fluoride, sodium fluoride, ? Rie T Rengelicol, Sodium Monofluorophosphate, Glo? Squirrel, dew bee bunch, bow, toki, safflower,
etc.: Gum bases for chewing gum include natural chicle and vinyl acetate; excipients for troches and chewable tablets include lactose, crystalline cellulose, sucrose, and the like. Further, for the purpose of improving the feeling of use, a suitable flavoring agent such as peppermint, spearmint, anethole, etc. may be added.
次に、酸処理ゼオライトが水の共存下で4優れた口臭原
因物質吸着作用を持つことを証明する実験例を示す。こ
の実験では主要な口臭原因物質であるメチルメルカプタ
ンと合成ゼオライトのひとつである平均粒子径3.63
μの4A型ゼオライトを用いた。すなわち、10−のガ
ラス製栓付試験管に10〜100嘘のゼオライトサンプ
ルを精密に秤り取り、129mメチルメルカプタン水溶
液を3−加えて栓をし、よく震盪攪拌し、20℃で15
分間靜置後DBC−Conway法で遊離のメチルメル
カプタンを定量した。DBC−Conway法は、BD
C−OH(4、4−ピスーゾメチルアミノゾフェニルカ
ルゴニルカルピノール)が酸性でカル?ニウムインモニ
ウムイオンにもトラく強い青色を呈するが、これにSH
化合物を反応させると速やかにこの青色が消失すること
を利用するものである。具体的には、内部に隔てられた
二つの貯留部を持つ密閉容器であるConwaydis
h (柴田製微量検測器)の一方の貯留部にBDC溶液
(0,1%BDC−OHアセトン溶液50 pi、 p
H6,5の50 mM Tris −MaleateB
uffer 10ml、10%ラウリル硫酸ナトリウム
水溶液100μlを混合したもの)を2−人れ、他方の
貯留部にサンプルを3−人れた後、密封し、37℃で2
時間インキュベートした。Next, an experimental example will be shown to prove that acid-treated zeolite has an excellent adsorption effect on 4 substances that cause bad breath in the coexistence of water. In this experiment, we used methyl mercaptan, a major substance that causes bad breath, and synthetic zeolite, which has an average particle size of 3.63.
μ 4A type zeolite was used. That is, 10 to 100 zeolite samples were accurately weighed into a 10-sized glass test tube with a stopper, 129 m aqueous methyl mercaptan solution was added thereto, the stopper was sealed, the tube was shaken thoroughly, and the zeolite sample was heated to 20°C for 15 minutes.
After standing for a minute, free methyl mercaptan was determined by the DBC-Conway method. DBC-Conway method is BD
C-OH (4,4-pisuzomethylaminozophenylcargonylcarpinol) is acidic and carpinol? Immonium ion also exhibits a very strong blue color, but SH
This method takes advantage of the fact that this blue color disappears quickly when a compound is reacted. Specifically, the Conwaydis is a sealed container with two internally separated reservoirs.
BDC solution (0.1% BDC-OH acetone solution 50 pi, p
50 mM Tris-MaleateB of H6,5
After adding 10 ml of buffer and 100 µl of 10% sodium lauryl sulfate aqueous solution to the other reservoir, place 3 samples into the other reservoir, seal, and incubate at 37°C for 2 hours.
Incubated for hours.
その後、室温まで放冷した後HDC溶液の610!■で
の吸光度を測定した。別に同様の方法で検量線を作成し
、遊離のメチルメルカプタン量を算出した。第1図にそ
の結果をしめす。After that, the HDC solution was cooled to room temperature and the 610! The absorbance at (3) was measured. Separately, a calibration curve was prepared in the same manner, and the amount of free methyl mercaptan was calculated. Figure 1 shows the results.
縦軸はゼオライトに吸着せずに残存した遊離のメチルメ
ルカプタン量を示し、横軸は添加したゼオライトの量を
示している。この図から、酸処理ゼオライトのIOQは
無処理ゼオライトの5089と同等の効果を有すること
、すなわち、酸処理ゼオライトは無処理ゼオライトに比
べて口臭原因物質吸着作用に優れていることが判る。The vertical axis shows the amount of free methyl mercaptan remaining without being adsorbed on the zeolite, and the horizontal axis shows the amount of added zeolite. From this figure, it can be seen that the IOQ of the acid-treated zeolite has the same effect as the untreated zeolite 5089, that is, the acid-treated zeolite is superior to the untreated zeolite in adsorbing substances that cause bad breath.
次に、実施例を示して本発明を更に詳細に説明するが、
本発明はこれらの実施例に限定されない。Next, the present invention will be explained in more detail by showing examples.
The invention is not limited to these examples.
実施例1
次の各成分を脱気混合し、ペースト状の綽歯磨剤とした
。Example 1 The following components were degassed and mixed to form a paste-like toothpaste.
歯磨用リン酸水素カルシウム 35.0無
水ケイ酸 zOカル?キシメチル
セルロースナトリウム 20ラウリル硫酸ナト
リウム 1.7サツカリンナトリ
ウム 0.2グリセリン
10.070%ソルビット液
15.0メチルノQラベン
0.1香 料
0.9計 100.0W蚤
*11M硫酸水溶液で処理し、pH7,0としたもの。Calcium hydrogen phosphate for toothpaste 35.0 Silicic anhydride zOcal? Sodium oxymethylcellulose 20 Sodium lauryl sulfate 1.7 Sodium saccharin 0.2 Glycerin
10.070% sorbitol liquid
15.0 Methyl Q Laben
0.1 fragrance
0.9 total 100.0W flea * Treated with 11M sulfuric acid aqueous solution to pH 7.0.
実施例2 練歯磨剤
次の各成分を脱気混合し、半透明な外観の練歯磨剤とし
た。Example 2 Toothpaste The following ingredients were degassed and mixed to form a toothpaste with a translucent appearance.
酸処理ゼオライト*2
(4Afi、平14粒子f4 Z Op )
5°OW %無水ケイ酸
25.0カル?キシメチルセルロースナトリウム
1.5ラウリル硫酸ナトリウム
1.5サツカυ“ンナトリウム
0.2グリセリン 20.07
0%ソルビット液 35.0プ
チルノQラペン 0.1香
料 0.9着
色 剤 微
量精 製 水 バランス計
100.0W%
*21M塩酸水溶液で処理し、p)(s、oとしたもの
。Acid-treated zeolite *2 (4Afi, Hei 14 grain f4 Z Op)
5°OW% silicic anhydride
25.0 Cal? Sodium oxymethylcellulose
1.5 Sodium lauryl sulfate
1.5 Sodium
0.2 Glycerin 20.07
0% Sorbitol liquid 35.0 Butylno Q Lapen 0.1 Fragrance 0.9 Coloring agent Slight
Refining water balance meter
100.0W% *Treated with 21M hydrochloric acid aqueous solution and converted to p)(s, o).
実施例3 次の各成分を混合し、粉末状の歯磨剤とした。Example 3 The following components were mixed to form a powdered dentifrice.
沈降炭酸カルシウム 70.0ラウロイルグ
ルタミン酸ナトリウム 0.5シヨ糖脂肪
酸エステル Z5サッカリンナトリウム
0.1香 料
微 置針 too、o
w%
*SIMクエン酸水溶液で処理し、pH7,5としたも
の。Precipitated calcium carbonate 70.0 Sodium lauroyl glutamate 0.5 Sucrose fatty acid ester Z5 Sodium saccharin 0.1 Flavor
Fine needle too, o
w% *SIM treated with citric acid aqueous solution to pH 7.5.
実施例4
次の各成分を混合し、精製水を少量加えてペースト状に
した後円板状に成型し、乾燥させてトローチ剤を得た。Example 4 The following components were mixed and a small amount of purified water was added to form a paste, which was then molded into a disk shape and dried to obtain a lozenge.
クエン酸 0.1ステビオサイ
ド 0.05デキストリン
10.0アラビアガム 4
.0香 料 微
量乳 糖
バランス計 100.0W優
本41M酒石酸水溶液で処理し、pH8,0としたもの
。Citric acid 0.1 Stevioside 0.05 Dextrin
10.0 Gum Arabic 4
.. 0 flavors, trace lactose
Balance meter 100.0W Yuhon Treated with 41M tartaric acid aqueous solution and adjusted to pH 8.0.
実施例5 次の各成分を混合し、乾式打錠して噛み砕き錠を得た。Example 5 The following components were mixed and dry-compressed to obtain crushed tablets.
乾燥水酸化アルミニウムゲル 45.0ス
テアリン酸マグネシウム 1、Oアス
ノ9ルテーム 0.1香
料 微 量
メタケイ酸アルミン酸マグネシウム バランス
計 100.0W%
*SIMコ・・り酸水溶液で処理し、pH7,2とした
もの。Dry aluminum hydroxide gel 45.0 Magnesium stearate 1, O Asno 9 Luteme 0.1 Fragrance Trace amount Magnesium aluminate metasilicate Balance meter 100.0 W% * Treated with SIM co-phosphoric acid aqueous solution, pH 7.2 What was said.
実施例6
次の成分を加熱線合し、成型してチューインガムとした
。Example 6 The following ingredients were heat-coated and molded into chewing gum.
ガム基剤 20.0コーンシロツ
ゾ 20.0香 料
微 量粉末シヨ糖
バランス計 100.0Wi
6
*s I M リンゴ酸水溶液で処理し、pH6,5と
したもの。Gum base 20.0 Corn syrup 20.0 Flavor
Small amount of powdered sucrose
Balance meter 100.0Wi
6 *s IM Treated with malic acid aqueous solution to pH 6.5.
第1図は水共存系でのゼオライトのメチルメルカゾタン
吸着除去作用を示したものである。
以上Figure 1 shows the adsorption and removal effect of methylmercazotane by zeolite in a water-coexisting system. that's all
Claims (1)
酸処理ゼオライトを含有することを特徴とする口腔用組
成物。 2、酸処理ゼオライト含量が全組成の1〜99重量%で
ある特許請求の範囲第1項記載の口腔用組成物。 3、ゼオライトがA型ゼオライト、4A型ゼオライト、
X型ゼオライト、Y型ゼオライト及びモルデナイトより
成る群から選ばれるものである特許請求の範囲第1項記
載の口腔用組成物。 4、酸処理ゼオライトの平均粒径が1〜10μmである
特許請求の範囲第1項又は第2項記載の口腔用組成物。[Scope of Claims] 1. An oral composition characterized by containing acid-treated zeolite, which is obtained by treating zeolite with an acid to have a pH of 9 or less. 2. The oral composition according to claim 1, wherein the acid-treated zeolite content is 1 to 99% by weight of the total composition. 3. Zeolite is type A zeolite, type 4A zeolite,
The oral composition according to claim 1, which is selected from the group consisting of X-type zeolite, Y-type zeolite, and mordenite. 4. The oral composition according to claim 1 or 2, wherein the acid-treated zeolite has an average particle size of 1 to 10 μm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29445786A JPS63146809A (en) | 1986-12-10 | 1986-12-10 | Composition for oral cavity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29445786A JPS63146809A (en) | 1986-12-10 | 1986-12-10 | Composition for oral cavity |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63146809A true JPS63146809A (en) | 1988-06-18 |
JPH0432049B2 JPH0432049B2 (en) | 1992-05-28 |
Family
ID=17808029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29445786A Granted JPS63146809A (en) | 1986-12-10 | 1986-12-10 | Composition for oral cavity |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63146809A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013520430A (en) * | 2010-02-19 | 2013-06-06 | ジェイ・エム・フーバー・コーポレーション | Silica material to reduce bad breath |
-
1986
- 1986-12-10 JP JP29445786A patent/JPS63146809A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013520430A (en) * | 2010-02-19 | 2013-06-06 | ジェイ・エム・フーバー・コーポレーション | Silica material to reduce bad breath |
Also Published As
Publication number | Publication date |
---|---|
JPH0432049B2 (en) | 1992-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2006255486B2 (en) | Dental mineralization | |
US5833952A (en) | Oral compositions | |
KR101308920B1 (en) | Composition and method for reducing demineralization of teeth | |
RU2531102C2 (en) | High-fluoride oral care composition and method for maintaining anti-caries activity | |
BRPI0707692A2 (en) | fluoride composition and methods for dental mineralization | |
AU2014295815A1 (en) | Compositions and methods for dental mineralization | |
KR102555722B1 (en) | Complex for sensitivity treatment | |
JPH0424323B2 (en) | ||
JPH0436228A (en) | Composition for oral cavity application | |
JPS63146809A (en) | Composition for oral cavity | |
Raven et al. | The efficacy of a combined zinc and triclosan system in the prevention of oral malodour | |
JP3336688B2 (en) | Oral composition | |
JPH0321003B2 (en) | ||
JPH0776167B2 (en) | Composition for eliminating breath odor | |
JPS5811927B2 (en) | Oral composition | |
JPH03128313A (en) | Dentifrice composition | |
JP2726490B2 (en) | Oral composition | |
JP3065947B2 (en) | Oral composition | |
JP2546263B2 (en) | Bad breath remover | |
JP2580656B2 (en) | Oral composition | |
JPH0331210A (en) | Composition for oral cavity | |
JPH0635374B2 (en) | Oral composition | |
JP2002068948A (en) | Composition for oral cavity and chewing composition | |
JP2001278763A (en) | Cariostatic agent | |
JPH056522B2 (en) |